13:33 EST Can-Fite BioPharma trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CANF:
- Is CANF a Buy, Before Earnings?
- Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
- Can-Fite: Complete response in patient with HCC treated with namodenoson
- Can-Fite BioPharma price target lowered to $18 from $34 at H.C. Wainwright
- Can-Fite shares “Lowe Syndrome Novel Treatment” with Japan orphan drug company